Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 212
of 11Next
2:

Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.

Happi CT, Gbotosho GO, Folarin OA, Milner D, Sarr O, Sowunmi A, Kyle DE, Milhous WK, Wirth DF, Oduola AM.

Malar J. 2006 Oct 4;5:82.

PMID: 17020611 [PubMed - indexed for MEDLINE]

3:

Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.

Wichmann O, Muehlberger N, Jelinek T, Alifrangis M, Peyerl-Hoffmann G, Muhlen M, Grobusch MP, Gascon J, Matteelli A, Laferl H, Bisoffi Z, Ehrhardt S, Cuadros J, Hatz C, Gjorup I, McWhinney P, Beran J, da Cunha S, Schulze M, Kollaritsch H, Kern P, Fry G, Richter J; European Network on Surveillance of Imported Infectious Diseases.

J Infect Dis. 2004 Nov 1;190(9):1541-6. Epub 2004 Sep 28.

PMID: 15478057 [PubMed - indexed for MEDLINE]

4:

Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.

Pimentel S, Nogueira F, Benchimol C, Quinhentos V, Bom J, Varandas L, do Rosário V, Bernardino L.

Malar J. 2006 Apr 5;5:30.

PMID: 16597338 [PubMed - indexed for MEDLINE]

6:

Malarone treatment failure not associated with previously described mutations in the cytochrome b gene.

Wichmann O, Muehlen M, Gruss H, Mockenhaupt FP, Suttorp N, Jelinek T.

Malar J. 2004 Jun 8;3:14.

PMID: 15186499 [PubMed - indexed for MEDLINE]

7:

Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.

Musset L, Pradines B, Parzy D, Durand R, Bigot P, Le Bras J.

J Antimicrob Chemother. 2006 Jan;57(1):110-5. Epub 2005 Nov 30.

PMID: 16319183 [PubMed - indexed for MEDLINE]

8:

Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.

Muehlen M, Schreiber J, Ehrhardt S, Otchwemah R, Jelinek T, Bienzle U, Mockenhaupt FP.

Trop Med Int Health. 2004 Mar;9(3):361-3.

PMID: 14996365 [PubMed - indexed for MEDLINE]

9:

Detection of atovaquone and Malarone resistance conferring mutations in Plasmodium falciparum cytochrome b gene (cytb).

Gil JP, Nogueira F, Strömberg-Nörklit J, Lindberg J, Carrolo M, Casimiro C, Lopes D, Arez AP, Cravo PV, Rosário VE.

Mol Cell Probes. 2003 Apr-Jun;17(2-3):85-9.

PMID: 12788029 [PubMed - indexed for MEDLINE]

10:

Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia.

Gebru T, Hailu A, Kremsner PG, Kun JF, Grobusch MP.

Malar J. 2006 Nov 21;5:112.

PMID: 17118179 [PubMed - indexed for MEDLINE]

11:

Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.

Musset L, Bouchaud O, Matheron S, Massias L, Le Bras J.

Microbes Infect. 2006 Sep;8(11):2599-604. Epub 2006 Aug 10.

PMID: 16962361 [PubMed - indexed for MEDLINE]

12:

Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria.

Fivelman QL, Butcher GA, Adagu IS, Warhurst DC, Pasvol G.

Malar J. 2002 Feb 8;1:1.

PMID: 12057021 [PubMed - indexed for MEDLINE]

13:

Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border.

Naoshima-Ishibashi Y, Iwagami M, Kawazu S, Looareesuwan S, Kano S.

Travel Med Infect Dis. 2007 Mar;5(2):132-4. Epub 2006 Sep 20.

PMID: 17298921 [PubMed - indexed for MEDLINE]

15:

Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.

Schwartz E, Bujanover S, Kain KC.

Clin Infect Dis. 2003 Aug 1;37(3):450-1. Epub 2003 Jul 18.

PMID: 12884171 [PubMed - indexed for MEDLINE]

17:

Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site.

Korsinczky M, Chen N, Kotecka B, Saul A, Rieckmann K, Cheng Q.

Antimicrob Agents Chemother. 2000 Aug;44(8):2100-8.

PMID: 10898682 [PubMed - indexed for MEDLINE]

18:

Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment.

Musset L, Le Bras J, Clain J.

Mol Biol Evol. 2007 Aug;24(8):1582-5. Epub 2007 May 7.

PMID: 17488741 [PubMed - indexed for MEDLINE]

19:

Prevalence of Plasmodium falciparum cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance.

Berry A, Senescau A, Lelièvre J, Benoit-Vical F, Fabre R, Marchou B, Magnaval JF.

Trans R Soc Trop Med Hyg. 2006 Oct;100(10):986-8. Epub 2006 May 11.

PMID: 16690094 [PubMed - indexed for MEDLINE]

20:

The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.

Na-Bangchang K, Manyando C, Ruengweerayut R, Kioy D, Mulenga M, Miller GB, Konsil J.

Eur J Clin Pharmacol. 2005 Sep;61(8):573-82. Epub 2005 Jul 23.

PMID: 16041597 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 212
of 11Next